Gynecologic Oncology Expert Witness

Overview

About Gynecologic Oncology Expert Witnesses

A gynecologic oncology expert decides whether a cancer of the female reproductive tract should have been found sooner, whether it was staged and operated on properly, and what any delay or surgical choice cost the patient. Many of these claims begin in a general gynecology or primary care office, so the oncologist often speaks to causation and prognosis rather than to the standard for the first doctor. This page covers ovarian, uterine, cervical and related cancers. General gynecologic care belongs to an OB-GYN, radiation treatment to a radiation oncologist, and pelvic floor repair to a urogynecology expert.

The expert reads office notes, ultrasound and imaging with the original files, pathology slides and reports, operative notes, tumor markers, referral records and treatment plans. A second look at the slides by a gynecologic pathologist often changes the discussion, so counsel should secure them early.

Delayed Diagnosis

The strength of a delay claim depends heavily on the cancer.

• Endometrial cancer. The National Cancer Institute says irregular vaginal bleeding is the most common presenting sign, that it generally occurs early, and that this is why most patients are diagnosed with highly curable stage I disease ¹. So a bleeding patient who went without evaluation can present a stronger claim, because the sign was there and early treatment works well
• Tamoxifen. NCI says it is important that patients on tamoxifen who have abnormal uterine bleeding receive follow-up examinations and biopsy of the endometrial lining ¹. That line gives the expert a clear question to ask
• Ovarian cancer. NCI says these cancers may not cause early signs or symptoms, and that when signs do appear the cancer is often advanced ². Symptoms include pain, swelling or pressure in the abdomen or pelvis, urinary urgency or frequency, and difficulty eating or feeling full ². Vague complaints make a missed-diagnosis claim harder, and also explain why persistent ones deserve a look

Causation is the center of most delay cases. The expert has to estimate the stage at the earlier date, how the disease would have behaved and whether treatment would have changed the result. That often means working backward from tumor size, marker trends and imaging. State law on lost chance differs a great deal, so the theory should be settled before the opinion is written.

Genetic Risk

Family history can be its own claim. NCI lists BRCA1 and BRCA2 variants among inherited risks, and says that for women at increased risk, prophylactic oophorectomy may be considered after age 35 if childbearing is complete ². A patient whose history suggested inherited risk may claim she was never told or referred for counseling. The expert looks at what was recorded, what guidance existed at the time and what a test or surgery would have changed.

Morcellation and Surprise Cancers

Tissue morcellation is the best-known recent dispute. FDA says that a hidden uterine sarcoma may be present in approximately 1 in 225 to 1 in 580 women undergoing surgery for uterine fibroids, based on published literature, and that there is no reliable method for predicting whether a woman with fibroids has a uterine sarcoma ³. It warns that morcellation can spread cancerous tissue within the abdomen and worsen long-term survival ³. It now recommends tissue containment systems when laparoscopic power morcellators are used ³, and in July 2026 it granted marketing authorization for an integrated morcellator and containment system ³. These cases can involve the surgeon and the device maker, and the date of surgery decides which warnings and labels applied.

Surgery and Referral

Operative claims often involve bowel, bladder or ureter injury during a difficult dissection. A known complication is not necessarily negligence, so the expert looks at whether it was recognized and repaired in time. Other disputes turn on whether a general gynecologist should have referred a suspicious mass, or operated without a gynecologic oncologist available. A surgeon's staging choices, including lymph node assessment, should be read against the guidance in force at that time.

Who Is Qualified

Look for a physician with subspecialty certification in gynecologic oncology who treats these cancers regularly. The American Board of Obstetrics and Gynecology says subspecialty certification is a voluntary process for board-certified OB-GYNs, and it lists gynecologic oncology among its subspecialties ⁴. A claim against a general gynecologist or primary care doctor may need a same-field witness on the standard of care. A pathologist reads the slides, and a medical oncologist may add to prognosis. Each opinion must stay within what a reliable method can support ⁵, and cancer treatment changes quickly, so the expert should work from the guidance in force on the date of care.

Qualifications

Qualifications to Look For

• ✓Subspecialty certification in gynecologic oncology
• ✓Active surgical and clinical practice at the time of the events
• ✓Direct experience with the cancer and operation at issue
• ✓Ability to work backward from stage, markers and imaging on causation
• ✓Familiarity with guidance in force on the date of care
• ✓Collaboration with a pathologist on slide review
• ✓Prior deposition or trial testimony on prognosis and lost chance

FAQ

Frequently Asked Questions